Pharmaziepraktikant in im Bereich Medical Information Intern
About the job
- You have completed or will soon complete the second section of pharmaceutical training (Second Pharmaceutical State Examination).
- You want to apply and deepen your knowledge in core areas of pharmacy, especially pharmacology, clinical pharmacy, pharmaceutical technology, and pharmaceutical chemistry, in drug information.
- You have a strong interest in pharmaceutical processes.
- You can confidently use standard software, including Microsoft Office.
- You have good German and English skills, spoken and written.
- Work in the Medical Information department.
- Contribute to answering complex questions from community and hospital pharmacists about the use, pharmaceutical quality, efficacy, and safety of the company's medicines.
- Support the efficient use of medicines by providing information about their effects, side effects, contraindications, interactions, and pharmacokinetic and pharmacodynamic properties.
- Advise customers on compounding with the company's products, correct preparation of medicines, and correct use of finished medicines and their special dosage forms.
- Record complaints and adverse events.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave